Thompson Craig B.

Thompson Craig B. is listed in filings as Director at Charles River Laboratories International Inc. This profile follows SEC Form 4 activity through May 12, 2026, including 7 public disclosures. Recent filings connect the profile to Charles River Laboratories International Inc (CRL) and Regeneron Pharmaceuticals Inc (REGN). The current snapshot covers public activity from Jan 6, 2025 to May 12, 2026. Reported amounts are shown as $255.4K to $280.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.